These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

442 related items for PubMed ID: 1872016

  • 21. The combination measles, mumps, rubella and varicella vaccine in healthy children.
    Arbeter AM, Baker L, Starr SE, Plotkin SA.
    Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection.
    Frenkel LM, Nielsen K, Garakian A, Cherry JD.
    Arch Pediatr Adolesc Med; 1994 Jan; 148(1):57-60. PubMed ID: 8143011
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M, Berger R, Just V.
    Dev Biol Stand; 1986 Jan; 65():85-8. PubMed ID: 3030863
    [Abstract] [Full Text] [Related]

  • 27. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children.
    Watson BM, Laufer DS, Kuter BJ, Staehle B, White CJ, Starr SE.
    J Infect Dis; 1996 Mar; 173(3):731-4. PubMed ID: 8627041
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Measles, mumps, rubella antibody surveillance: pilot study in Grampian, Scotland.
    Narayan KM, Moffat MA.
    Health Bull (Edinb); 1992 Jan; 50(1):47-53. PubMed ID: 1612895
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme.
    Tharmaphornpilas P, Yoocharean P, Rasdjarmrearnsook AO, Theamboonlers A, Poovorawan Y.
    J Health Popul Nutr; 2009 Feb; 27(1):80-6. PubMed ID: 19248651
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
    Vázquez Fernández E, López Rois F, Vázquez Carrete JA, Gómez Tato B, Alvarez Ares M.
    An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH, Lee CY, Chih TW, Lee PI, Chang LY, Lin YJ, Hsu CM, Huang LM.
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [Abstract] [Full Text] [Related]

  • 39. Serologic response to measles-mumps-rubella vaccine among children with upper respiratory tract infection.
    Cilla G, Peña B, Marimón JM, Pérez-Trallero E.
    Vaccine; 1996 Apr; 14(6):492-4. PubMed ID: 8782345
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.